title: Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
abstract: Hutchinson-Gilford progeria syndrome (HGPS) is a rare precocious aging syndrome caused by mutations in LMNA that lead to synthesis of a mutant form of prelamin A, generally called progerin, that cannot be processed to mature lamin A. Most HGPS patients have a recurrent heterozygous de novo mutation in exon 11 of LMNA, c.1824C>T/p.G608G; this synonymous mutation activates a nearby cryptic splice donor site, resulting in synthesis of the mutant prelamin A, progerin, which lacks 50 amino acids within the carboxyl-terminal domain. Abnormal splicing is incomplete, so the mutant allele produces some normally-spliced transcripts. Nevertheless, the synthesis of progerin is sufficient to cause misshapen nuclei in cultured cells and severe disease phenotypes in affected patients. Here we present two patients with extraordinarily severe forms of progeria caused by unusual mutations in LMNA. One had a splice site mutation (c.1968+1G>A; or IVS11+1G>A), and the other had a novel synonymous coding region mutation (c.1821G>A/p.V607V). Both mutations caused very frequent use of the same exon 11 splice donor site that is activated in typical HGPS patients. As a consequence, the ratios of progerin mRNA and protein to wild-type were higher than in typical HGPS patients. Fibroblasts from both patients exhibited nuclear shape abnormalities typical of HGPS, and cells treated with a protein farnesyltransferase inhibitor exhibited fewer misshapen nuclei. Thus, farnesyltransferase inhibitors may prove to be useful even when progerin expression levels are higher than those in typical HGPS patients.
authors.affiliation: Department of Internal Medicine, Renal Division, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
authors.forename: Casey L
authors.initials: CL
authors.lastname: Moulson
authors.forename: Loren G
authors.initials: LG
authors.lastname: Fong
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Gardner
authors.forename: Emily A
authors.initials: EA
authors.lastname: Farber
authors.forename: Gloriosa
authors.initials: G
authors.lastname: Go
authors.forename: Annalisa
authors.initials: A
authors.lastname: Passariello
authors.forename: Dorothy K
authors.initials: DK
authors.lastname: Grange
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Young
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Miner
mesh_terms: D002478:Cells, Cultured; D002675:Child, Preschool; D004252:DNA Mutational Analysis; D005786:Gene Expression Regulation; D006801:Humans; D007231:Infant, Newborn; D034904:Lamin Type A / Q000235:genetics*; D008297:Male; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D011371:Progeria / Q000235:genetics*; D011498:Protein Precursors / Q000235:genetics*; D015854:Up-Regulation
chemical_list: C494847:LMNA protein, human; D034904:Lamin Type A; D009687:Nuclear Proteins; D011498:Protein Precursors; C090764:prelamin A